The role of biomarkers in the prevention of globally important diseases
Point-of-care testing and the control of infectious diseases
Biomarkers of tuberculosis: a research roadmap
The mechanistic, diagnostic and prognostic utility of biomarkers in severe malaria
Are we closer to finding biomarkers for identifying acute drug-induced liver injury?
miRNAs as biomarkers for brain metastasis of breast cancer
MPO is a potential biomarker of acute graft-versus-host disease
NMR profiling of urinary metabolites could improve hepatocellular carcinoma diagnosis
Prognostic value of VEGF in prostate cancer disputed in large retrospective study
Computed tomography imaging may aid in the prediction of survival in some metastatic melanoma patients
Much needed potential biomarker identified for peripartum cardiomyopathy
Genomic analysis identifies novel prognostic signature for breast cancer
A gripping problem: cardiac biomarkers in patients with intermittent claudication
A sticky situation: fibrinogen and coronary artery disease
Clot disruption: the role of D-dimer testing for deep vein thrombosis
Conference Scene: ISOBM 2013 in Israel: part 1: biomarkers - where we are now?
Conference Scene: ISOBM 2013 in Israel: part 2: biomarkers – a challenging issue for futher investigation
Plasma NGAL similarly predicts acute kidney injury in sepsis and nonsepsis
Relationship of adipokines (adiponectin, resistin and RBP4) with metabolic syndrome components in pubertal obese children
Length of psychiatric hospitalization is correlated with CYP2D6 functional status in inpatients with major depressive disorder
Clinical use of biomarkers for toxicant-induced acute kidney injury
Assessing the functional properties of high-density lipoproteins: an emerging concept in cardiovascular research
Impact of expression of the uPA system in sarcomas
High peripheral levels of h-FABP are associated with poor prognosis in end-stage heart failure patients with mechanical circulatory support
Acknowledgements
Erratum